Supraventricular tachycardia treatment
Pro Research Analysisby 
Searched over 200M research papers
Initial Assessment and Diagnosis of Supraventricular Tachycardia (SVT)
The first step in treating supraventricular tachycardia is to determine if the patient is hemodynamically stable and to confirm that symptoms are due to SVT. Identifying the specific type of SVT helps guide the best treatment approach. Reviewing the patient’s medical history is also important to avoid contraindications to certain therapies .
Non-Pharmacological and Acute Interventions for SVT
Vagal Maneuvers and Physical Techniques
For initial management, especially in stable patients, vagal maneuvers such as the Valsalva maneuver or applying iced water to the face (in infants) are recommended. These techniques can terminate SVT by increasing vagal tone and blocking conduction through the atrioventricular (AV) node. Iced water application is particularly effective and safe in neonates and young infants, with a high success rate and minimal complications 18.
Electrical Cardioversion
If the patient is unstable or if non-pharmacological methods fail, immediate electrical cardioversion is indicated. This is effective in restoring normal rhythm, especially in cases with hemodynamic compromise 18.
Pharmacological Treatment Options
Adenosine
Adenosine is the preferred first-line drug for acute termination of most paroxysmal SVTs involving the AV node. It works by causing a transient AV nodal block, rapidly converting SVT to sinus rhythm in the majority of cases (mean success rate of 93%). Adenosine acts quickly and has a very short half-life, with side effects such as chest discomfort and flushing that are brief and generally not serious. It is especially useful when vagal maneuvers are ineffective or not feasible. Adenosine is also favored over verapamil due to its safety profile, particularly in patients with heart failure or wide-complex tachycardia 1410.
Other Medications
Verapamil and digoxin have been used, but verapamil can be dangerous in infants and is not recommended in this group. Digoxin is sometimes used in infants and in fetal SVT, but its effectiveness is variable and there is a risk of overdose. Flecainide and sotalol are considered as alternatives, especially in fetal SVT, with some evidence suggesting flecainide may be more effective as a first-line treatment 78.
Catheter Ablation for Chronic and Refractory SVT
Catheter ablation has become the treatment of choice for chronic or recurrent SVT in both adults and children, especially when medications are ineffective or not tolerated. Radiofrequency ablation of the slow pathway in AV nodal reentrant tachycardia (AVNRT) is highly effective and carries a low risk of complications, such as AV block. The latest guidelines strongly recommend catheter ablation for most types of SVT, except for inappropriate sinus tachycardia and multifocal atrial tachycardia 36.
Special Considerations in Infants and Pediatrics
In infants, SVT is the most common arrhythmia and is often managed with antiarrhythmic medications, but there is significant variation in practice and a notable risk of adverse events. Adenosine is the most commonly used abortive therapy, but recurrence and complications are not uncommon. Iced water application is a safe and effective non-pharmacological option in this age group 810.
Health Disparities in SVT Treatment
There are disparities in access to advanced treatments like ablation among pediatric patients, with non-White, younger, and certain demographic groups being less likely to receive ablation therapy. This highlights the need for equitable healthcare delivery in SVT management .
Conclusion
The treatment of supraventricular tachycardia involves a stepwise approach: starting with vagal maneuvers, progressing to adenosine for acute termination, and considering electrical cardioversion in unstable patients. Catheter ablation is now the preferred long-term solution for most SVTs, offering high success rates and low risk. Special considerations are needed for infants and pediatric patients, and ongoing efforts are required to address disparities in care.
Sources and full results
Most relevant research papers on this topic